These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 10220509

  • 1. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.
    Bosch-Marcè M, Clària J, Titos E, Masferrer JL, Altuna R, Poo JL, Jiménez W, Arroyo V, Rivera F, Rodés J.
    Gastroenterology; 1999 May; 116(5):1167-75. PubMed ID: 10220509
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
    Wallace JL, McKnight W, Reuter BK, Vergnolle N.
    Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G, Panzetta G.
    G Ital Nefrol; 2002 Sep; 19(2):199-203. PubMed ID: 12195419
    [Abstract] [Full Text] [Related]

  • 8. Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.
    Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B.
    J Hypertens; 2004 Jan; 22(1):191-8. PubMed ID: 15106811
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development.
    Kömhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Harris RC, Breyer MD.
    Kidney Int; 2000 Feb; 57(2):414-22. PubMed ID: 10652018
    [Abstract] [Full Text] [Related]

  • 10. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
    Fujihara CK, Antunes GR, Mattar AL, Andreoli N, Malheiros DM, Noronha IL, Zatz R.
    Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
    [Abstract] [Full Text] [Related]

  • 11. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
    Blume C, Heise G, Mühlfeld A, Bach D, Schrör K, Gerhardz CD, Grabensee B, Heering P.
    Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
    [Abstract] [Full Text] [Related]

  • 12. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake.
    Rodríguez F, Llinás MT, González JD, Rivera J, Salazar FJ.
    Hypertension; 2000 Aug; 36(2):276-81. PubMed ID: 10948090
    [Abstract] [Full Text] [Related]

  • 13. Do COX-2 inhibitors reduce renal fibrosis?
    Harding P.
    J Hypertens; 2004 Jan; 22(1):43-5. PubMed ID: 15106792
    [No Abstract] [Full Text] [Related]

  • 14. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S, Johns EJ.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
    [Abstract] [Full Text] [Related]

  • 15. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors.
    Gambaro G, Perazella MA.
    J Intern Med; 2003 Jun; 253(6):643-52. PubMed ID: 12755960
    [Abstract] [Full Text] [Related]

  • 16. Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.
    Harding P, Carretero OA, Beierwaltes WH.
    J Hypertens; 2000 Aug; 18(8):1107-13. PubMed ID: 10954003
    [Abstract] [Full Text] [Related]

  • 17. Effect of cyclooxygenase-2 inhibition on renal function after renal ablation.
    Sanchez PL, Salgado LM, Ferreri NR, Escalante B.
    Hypertension; 1999 Oct; 34(4 Pt 2):848-53. PubMed ID: 10523372
    [Abstract] [Full Text] [Related]

  • 18. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 19. Effects of lysine clonixinate and ketorolac tromethamine on prostanoid release from various rat organs incubated ex vivo.
    Pallapies D, Salinger A, Meyer zum Gottesberge A, Atkins DJ, Rohleder G, Nagyiványi P, Peskar BA.
    Life Sci; 1995 Jan 01; 57(2):83-9. PubMed ID: 7603299
    [Abstract] [Full Text] [Related]

  • 20. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
    Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M.
    Clin Pharmacol Ther; 1999 Jul 01; 66(1):76-84. PubMed ID: 10430112
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.